Reducing the antigen prevalence target threshold for stopping and restarting mass drug administration for lymphatic filariasis elimination: a model-based cost-effectiveness simulation in Tanzania, India and Haiti (Clinical Infectious Diseases, 2024)

(untitled) - Antony Oliver, MC; Graham, M; Gass, KM; Medley, GF; Clark, J; Davis, EL; Reimer, LJ; King, JD; Pouwels, KB; Hollingsworth, TD